SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gillian K. Rosenberg, Sam Lattimore, Susan R. Brailsford, Patricia E. Hewitt, Kate I. Tettmar, Alan D. Kitchen, Samreen Ijaz, Richard S. Tedder, Acute hepatitis B in blood donors over a 5-year period in England and North Wales: who is getting infected?, Transfusion, 2014, 54, 6
  2. 2
    Fen Liu, Xiwei Wang, Fang Wei, Huaidong Hu, Dazhi Zhang, Peng Hu, Hong Ren, Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis, Virology Journal, 2014, 11, 1, 59

    CrossRef

  3. 3
    Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B, Clinical and Molecular Hepatology, 2014, 20, 3, 274

    CrossRef

  4. 4
    Rong-Quan Fu, Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot study, Medical Science Monitor, 2013, 19, 751

    CrossRef

  5. 5
    Yan Zhang, Song He, Qing-Ling Li, Jin-Jun Guo, Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy, Virus Research, 2013, 177, 2, 156

    CrossRef

  6. 6
    Xiao-Lin Deng, Qing-Ling Li, Jin-Jun Guo, Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy, Virus Genes, 2013, 47, 1, 1

    CrossRef

  7. 7
    Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee, Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients, Clinical and Molecular Hepatology, 2013, 19, 3, 273

    CrossRef

  8. 8
    Gillian K. Rosenberg, Sam Lattimore, Susan R. Brailsford, Patricia E. Hewitt, Kate I. Tettmar, Alan D. Kitchen, Samreen Ijaz, Richard S. Tedder, The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010, Transfusion, 2013, 53, 10pt2
  9. 9
    Francisco C A Mello, Bárbara V Lago, Lia L Lewis-Ximenez, Carlos A Fernandes, Selma A Gomes, Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients, BMC Microbiology, 2012, 12, 1, 96

    CrossRef

  10. 10
    S. Ijaz, R. Szypulska, N. Andrews, R. S. Tedder, Investigating the impact of hepatitis B virus surface gene polymorphism on antigenicity using ex vivo phenotyping, Journal of General Virology, 2012, 93, Pt_11, 2473

    CrossRef

  11. 11
    Monique I. Andersson, Nicola Low, Charles J. Irish, David Carrington, Matthew Hickman, Richard Myers, Chong-Gee Teo, Samreen Ijaz, Molecular epidemiology of a large community-based outbreak of hepatitis B in Bristol, UK, Journal of Clinical Virology, 2012, 53, 2, 125

    CrossRef

  12. 12
    Sang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, Joo-Hyun Sohn, Kwan-Sik Lee, Dong Joon Kim, Teerha Piratvisuth, Man Fung Yuen, Anuchit Chutaputti, You-Chen Chao, Aldo Trylesinski, Claudio Avila, Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B, Hepatology International, 2012, 6, 4, 696

    CrossRef

  13. 13
    Li-Chun Wang, En-Qiang Chen, Jing Cao, Li Liu, Li Zheng, Da-Jiang Li, Lu Xu, Xue-Zhong Lei, Cong liu, Hong Tang, De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients, Hepatology International, 2011, 5, 2, 671

    CrossRef

  14. 14
    Zhao Wang, Xiao-Ling Wu, Wei-Zheng Zeng, Hui Xu, Yong Zhang, Jian-Ping Qin, Ming-De Jiang, Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment, Virology Journal, 2011, 8, 1, 388

    CrossRef

  15. 15
    L.-C. Wang, E.-Q. Chen, J. Cao, L. Liu, J.-R. Wang, B.-J. Lei, H. Tang, Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy, Journal of Viral Hepatitis, 2010, 17, 3
  16. 16
    Xiangdong David Ren, Hui Nie, Ju-Tao Guo, HBV Drug Resistance Development, Testing, and Prevention, Current Hepatitis Reports, 2010, 9, 4, 223

    CrossRef

  17. 17
    Adele L McCormick, Ruth L Goodall, Aengus Joyce, Nicaise Ndembi, Mike Chirara, Pauline Katundu, Sarah Walker, David Yirrell, Charlie F Gilks, Deenan Pillay, Lack of Minority K65R-Resistant Viral Populations Detected After Repeated Treatment Interruptions of Tenofovir/Zidovudine and Lamivudine in a Resource-Limited Setting, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 54, 2, 215

    CrossRef

  18. 18
    M. A. Beale, S. Ijaz, R. S. Tedder, The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants, Journal of General Virology, 2010, 91, 1, 68

    CrossRef

  19. 19
    Yun–Fan Liaw, Edward Gane, Nancy Leung, Stefan Zeuzem, Yuming Wang, Ching Lung Lai, E. Jenny Heathcote, Michael Manns, Natalie Bzowej, Junqi Niu, Steven–Huy Han, Seong Gyu Hwang, Yilmaz Cakaloglu, Myron J. Tong, George Papatheodoridis, Yagang Chen, Nathaniel A. Brown, Efsevia Albanis, Karin Galil, Nikolai V. Naoumov, 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B, Gastroenterology, 2009, 136, 2, 486

    CrossRef

  20. 20
    Donatella Vincenti, Mariacarmela Solmone, Anna Rosa Garbuglia, Fabio Iacomi, Maria Rosaria Capobianchi, A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations, Journal of Virological Methods, 2009, 159, 1, 53

    CrossRef

  21. 21
    H.L. Zaaijer, R.B. Takkenberg, C.J. Weegink, S.P.H. Rebers, S. Menting, H.W. Reesink, J. Schinkel, R. Molenkamp, Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir, Journal of Medical Virology, 2009, 81, 3
  22. 22
    Hyun Wook Jung, Moon Seok Choi, Kap Hyun Kim, Sung Hyun Park, Kwak Keum Yeon, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients, The Korean Journal of Hepatology, 2009, 15, 1, 52

    CrossRef